With aspirin use in the elderly controversial because of their higher bleeding risk, the 2015 Beers Criteria by the American Geriatrics Society previously advised using caution in administering aspirin for primary prevention of cardiovascular disease for adults over the age of 80 and the 2002 ACC/AHA guidelines recommended that the decision to start low-dose aspirin in adults 60-69 with a 10 percent or greater 10-years cardiovascular disease risk should be an individual one.
Now, the guidelines for use of low dose aspirin in healthy elderly for the primary prevention of cardiovascular events has changed following trials and a review of clinical studies. The 2019 updated recommendations for facilities are as follows:
As a result of this updated guidance, facilities should reevaluate their policies and practices regarding aspirin use. Since low-dose aspirin is not recommended for use in adults 70 and over for primary prevention of cardiovascular disease because of the increased chance of bleeding, which holds a greater risk of harm than benefit, organizations should individualize care to determine if use of aspirin is appropriate.
To learn more about optimal medication therapy for your residents for improved outcomes, compliance and savings, contact PharMerica at info@PharMerica.com or (800) 564-1640.Download PDF